Author

Sumit Bhushan

Observed names: SUMIT BHUSHAN, Sumit Bhushan⁵, Sumit Bhushan⁶

Institution: Glenmark Pharmaceuticals (India)

Observed institution: Glenmark Pharmaceuticals (India)

ORCID: 0009-0003-8940-8175

Observed ORCID: 0009-0003-8940-8175

OpenAlex ID: A5111192565

Real-World Evaluation of the Episoft® AC Moisturizer With Broad-Spectrum Sunscreen in the Management of Retinoid-Induced Dermatitis: A Retrospective Observational Study

2026 · Gaurav Nakra, Ashwini Modi, et al. · Cureus · 2

PDF

A Cross Sectional Study on the Drug Utilization of FDC of Telmisartan Plus Metoprolol in Patients with Hypertension Across Various Clinics in India

2026 · Saket Kant, Amit Sharma, et al. · 1

PDF

An Open-Label, Single-Arm, Multicenter, Prospective, Post-Marketing Study to Evaluate the Effectiveness and Safety of Fluticasone Furoate/Vilanterol (FF/VI) Dry Powder Inhaler (DPI) in the Management of Asthma Patients (PROMISE-OD)

2026 · Ankit Kumar, Sandeepkumar Gupta, et al. · Cureus · 1

PDF

Are Two Gliflozins Different: A Prospective Multicenter Randomized Study to Assess Effect of Remogliflozin Compared With Empagliflozin on Biomarkers of Heart Failure in Indian Patients With Type 2 Diabetes Mellitus with Chronic Heart Failure (REMIT-HF Study)

2024 · SHANTANU SENGUPTA, JAYAGOPAL PATHIYILBALAGOPALAN, et al. · Journal of Cardiac Failure · 1

Real World Usage of Teneligliptin and Metformin Fixed Dose Combination among Indian Patients with Type 2 Diabetes Mellitus in Indian Clinical Practice

2026 · Sanjay Arora, Geetha Lakshmi, et al. · Current Trends in Internal Medicine

PDF

Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal)

2026 · Uday Jadhav, Santanu Guha, et al. · International Journal of Nephrology and Renovascular Disease

PDF

Real-World Usage of Teneligliptin in Indian Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Multicenter Study

2026 · Jayesh Biyani, Ashwin Subramaniam, et al. · Current Trends in Internal Medicine

PDF

Hypertension An Open Access

2026 · Saket Kant, Amit Sharma, et al.

Effectiveness and Safety of Triple Combination of Sitagliptin + Pioglitazone + Metformin In T2DM Patients: a Retrospective, Multi-Centre Study

2026 · Alok Agarwal, Mehul Sundesha, et al. · Current Trends in Internal Medicine

PDF

A Drug Utilization Study To Assess The Usage Of The Fixed-Dose Combination (FDC) Of Teneligliptin + Dapagliflozin In Indian Patients With Type2 Diabetes Mellitus (T2DM) At Various Clinics Across India

2026 · Vijay Neglur, Narasimman VKR, et al. · Current Trends in Internal Medicine

PDF

A Cross-Sectional Study on the Drug Utilization of Sacubitril-Valsartan (Sacu V) in Patients with Heart Failure with Reduced Ejection Fraction Across Various Clinics in India

2026 · Ankeet Dedhia, Anuj Bhasin, et al. · Cardiology Research and Cardiovascular Medicine

PDF

Real-world Drug Utilization of Fixed-Dose Combination of Sitagliptin + Dapagliflozin in Type 2 Diabetes Mellitus Patients Across India: A Cross-sectional Multicenter Study

2026 · Naresh Dang¹, Rajiv Lochan², et al. · Journal of Diabetes and Treatment

PDF

Real-World Drug Utilization of Fixed-Dose Combination Sitagliptin, Dapagliflozin, and Metformin in Type 2 Diabetes Mellitus Across Clinics in India: A Multicentric Observational Study

2026 · Rajesh Kumar Ghai¹, Milind Thanekar², et al. · Journal of Diabetes and Treatment

PDF

Mapping the Burden of Type 2 Diabetes: Real-World Evidence on Management Patterns, Comorbidities, and Glycemic Outcomes in India

2026 · Pankaj Aneja, Rahul Medidar, et al. · Journal of Diabetes and Treatment

PDF

Comparative Efficacy and Safety of Remogliflozin 100 mg Versus Dapagliflozin 10 mg in Patients with T2DM and CKD: A Randomized, Open-Label Study

2026 · Sumit Bhushan, Chaitanya Sawant, et al. · Journal of Nephrology & Endocrinology Research

PDF

PROMISE‑MINO: A Prospective, Open‑Label, Multicenter, Single‑Arm, Phase IV Study of the Safety, Local Tolerability, and Efficacy of Topical Minocycline Hydrochloride 4% Gel in Indian Patients With Moderate‑to‑Severe Acne Vulgaris

2026 · Vishalakshi Viswanath, Swetalina Pradhan, et al. · Cureus

PDF

An Open-Label, Single-Arm, Multicentric, Prospective, Phase IV Study to Evaluate the Safety and Effectiveness of Indacaterol/Mometasone/Glycopyrronium Dry Powder Inhaler (DPI) in the Management of Asthma Patients (OASIS Study)

2025 · Saurabh Karmakar, Suresh G Bhate, et al. · Cureus

PDF

Effectiveness and Safety of Glycopyrronium–Formoterol–Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study

2025 · Anjali R. Nath, Adesh Kumar, et al. · Advances in respiratory medicine

PDF

The Indian REgistry on Current Patient PrOfiles and TReatment TrenDs in Hypertension (RECORD): Final Outcomes of the Real-world Observational Study

2023 · Girish C Rajadhyaksha, Himanshu Reddy, et al. · Journal of the Association of Physicians of India

Works count: 19

Citation count: 5

H-index: 1

I10-index: